Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,952,668
+$473,550 QoQ
Shares Held
19,501
+6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#1,621
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Zhang Financial LLC holds $31,257,937 across 10 Drug Manufacturers - General names. JNJ ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
37,000 | $9,310,680 | |
| 2 | AMGN |
Amgen Inc
|
21,288 | $7,708,810 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
19,501 | $4,952,668 | |
| 4 | LLY |
ELI LILLY & Co
|
3,795 | $4,551,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,571 | $3,028,873 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,636 | $459,372 | |
| 7 | AZN |
Astrazeneca PLC
|
2,270 | $430,437 | |
| 8 | PFE |
Pfizer Inc
|
14,553 | $350,436 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,952,668 | 19,501 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,479,118 | 18,324 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,802,309 | 13,541 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,314,783 | 12,484 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,679,387 | 17,541 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,917,125 | 17,590 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,790,395 | 12,380 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,724,318 | 10,640 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,531,902 | 10,481 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,691,842 | 10,695 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $4,106,117 | 26,197 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $4,552,884 | 29,232 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $4,735,196 | 28,608 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $3,899,490 | 25,158 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,298,071 | 24,331 | Shares | Sole | 2023-05-17 | |
| 2022-09-30 | $4,325,282 | 26,477 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $4,758,510 | 26,807 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $6,516,924 | 36,771 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,723,359 | 10,074 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,529,243 | 9,469 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $956,150 | 5,804 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $840,814 | 5,116 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $635,185 | 4,036 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $549,069 | 3,688 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $731,979 | 5,205 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $679,646 | 5,183 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||